Savvy Updates, 11/25/24:  FDA Petition to Approve Sotagliflozin, Dexcom & Oura, Late Eating Alters BG Levels, PharmaSens Insulin Pumps, FDA Approves Medtronic InPen Smart Insulin Pen, PBMs sue FTC over Insulin Litigation

Savvy Updates, 11/25/24: FDA Petition to Approve Sotagliflozin, Dexcom & Oura, Late Eating Alters BG Levels, PharmaSens Insulin Pumps, FDA Approves Medtronic InPen Smart Insulin Pen, PBMs sue FTC over Insulin Litigation

In this week’s issue of The Savvy Diabetic:  FDA Petition to Approve Sotagliflozin Dexcom & Oura Late Eating Alters BG Levels PharmaSens NEW Insulin Pumps FDA Approves Medtronic InPen Smart Insulin Pen PBMs sue FTC over Insulin Litigation YOU...
Savvy Updates, 11/4/24:  O5/iPhone, Abbott CGM & MRIs, FDA Rejects Sotagliflozin, Chinese Stem-Cell Therapies, Semaglutide & Arthritis, Beta Bionics & Libre 3 Plus, AI & Diabetic Cardiomyopathy, Insulcloud & Insulin Pens, Dexcom CCO Retires

Savvy Updates, 11/4/24: O5/iPhone, Abbott CGM & MRIs, FDA Rejects Sotagliflozin, Chinese Stem-Cell Therapies, Semaglutide & Arthritis, Beta Bionics & Libre 3 Plus, AI & Diabetic Cardiomyopathy, Insulcloud & Insulin Pens, Dexcom CCO Retires

In this week’s issue of The Savvy Diabetic:  Omnipod 5 & the iPhone App Abbott CGM Sensors OK in MRI FDA Rejects Sotagliflozin for T1D Chinese Stem Cell-Based Therapies Semaglutide for Knee Osteoarthritis Pain Beta Bionics Launches iLet with Abbott...
Savvy Updates 10/14/24:  GLP-1s, Medtronic Recall, Breakthrough T1D & TCOYD, Sotagliflozin & FDA Appeal, How PBMs Work, CVS Break Up?, Non-D Above TTIR, Tidepool Loop

Savvy Updates 10/14/24: GLP-1s, Medtronic Recall, Breakthrough T1D & TCOYD, Sotagliflozin & FDA Appeal, How PBMs Work, CVS Break Up?, Non-D Above TTIR, Tidepool Loop

In this week’s issue of The Savvy Diabetic:  GLP-1s & T1D: How they work, dosing & pharmacokinetics Medtronic Recall for Reduced Battery Life Breakthrough T1D & TCOYD: Research Highlights Sotagliflozin (for CKD) & FDA Advocacy NOW! How PBMs...
Savvy Updates, 8/5/24:  Tandem Mobi Expansion Plans, T1D Vision/Hearing Loss Need Access to D Tech, More on Dexcom & Geofencing, Spotlight on Creativity: Krista Sheneman

Savvy Updates, 8/5/24: Tandem Mobi Expansion Plans, T1D Vision/Hearing Loss Need Access to D Tech, More on Dexcom & Geofencing, Spotlight on Creativity: Krista Sheneman

Tandem CMO shares Mobi feedback, expansion plans by Elise Reuter for MedTechDive.com, 29 July 2024. Tandem Diabetes Care this year began a full launch of its smallest insulin pump, called Mobi, after the device received clearance from the Food and Drug Administration...
Skip to content